PAR 5.13% 20.5¢ paradigm biopharmaceuticals limited..

PAR -v- CUV, page-59

  1. 4,567 Posts.
    lightbulb Created with Sketch. 348
    say $1000 per treatment (some of which is patient funded, majority govt or private) x 3mil patients = $3bil revenues. current market cap is $256M...
    Last edited by Nige456: 24/06/19
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.